Results 101 to 110 of about 20,805 (196)

Antibody-dependent cellular cytotoxicity in HIV infection. [PDF]

AIDS, 2018
Forthal DN, Finzi A.
europepmc   +1 more source

Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition. [PDF]

J Immunother Cancer, 2018
Fenerty KE, Padget M, Wolfson B, Gameiro SR, Su Z, Lee JH, Rabizadeh S, Soon-Shiong P, Hodge JW.   +8 more
europepmc   +1 more source

Asymmetrical Fc engineering to enhance antibody-dependent cellular cytotoxicity (ADCC) [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Reduced antibody-dependent cellular cytotoxicity (ADCC) in juvenile parkinsonism.

Japanese Journal of National Medical Services, 1991
TANAKA, Masami, TANAKA, Hajime, SASAKI, Takemiki   +2 more
openaire   +1 more source

Antibody-Dependent Cellular Phagocytosis and Cytotoxicity in Patients With LGI1 and CASPR2 Encephalitis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Businaro P, Masciocchi S, Scaranzin S, Morandi C, Zuliani F, Malvaso A, Cerne D, Barone P, Toriello A, Arbasino C, Cenciarelli S, Volonghi I, Casagrande S, Nassani S, Currò-Dossi M, Micheli S, Fattapposta F, Bisecco A, Leone C, Marchioni E, Franciotta D, Spatola M, Zardini E, Benedetti L, Gastaldi M.   +24 more
europepmc   +1 more source

Molecular Profiling of Tisotumab Vedotin-Treated Patients Identifies Immune Pathways Associated with Clinical Activity. [PDF]

Clin Cancer Res
Sridhar S, Roukens MG, Yu CY, Dielen T, van Kessel-Welmers B, Si H, Xu S, Brady LK, Belete M, Bieda M, Shah KN, Aquino R, Gallagher D, Thalhauser CJ, Higgs BW, Fereshteh M, Jure-Kunkel M, Harris JR.   +17 more
europepmc   +1 more source

Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains. [PDF]

mBio
Melo C, Murphy T, Holmberg CS, Kelly M, McMahon EK, Lochner JS, Lynch RM, Bosque A.   +7 more
europepmc   +1 more source

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement. [PDF]

Oncotarget, 2017
Kline JB, Kennedy RP, Albone E, Chao Q, Fernando S, McDonough JM, Rybinski K, Wang W, Somers EB, Schweizer C, Grasso L, Nicolaides NC.   +11 more
europepmc   +1 more source

[Significance of the antibody-dependent cellular cytotoxicity (ADCC) test].

Reumatologia, 1982
M, Płachecka-Gutowska, B, Misiewicz-Półtorak   +1 more
openaire   +1 more source

Fc-engineering for improved cancer immunotherapy. [PDF]

Biochem Soc Trans
Borgman E, Le Gall C, Ploegh H, Pishesha N.   +3 more
europepmc   +1 more source